{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T17:35:02Z","timestamp":1770226502786,"version":"3.49.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Disseminated herpes zoster (DHZ) is defined by the involvement of more than two non-contiguous dermatomes or the presence of at least 20 lesions beyond the primary affected dermatome. The varicella-zoster virus (VZV) can lead to disseminated infection when the host\u2019s immune response is insufficient to halt cell-associated viremia. This study aimed to summarize the clinical characteristics and potential risk factors associated with DHZ and to identify and assess factors related to prognosis to enhance the prevention and management strategies for DHZ patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The demographic information of DHZ patients who presented to our department between January 2019 and January 2025 was retrospectively collected. Patients with a confirmed diagnosis of DHZ were monitored to identify morbidity risk factors and the incidence of postherpetic neuralgia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 109 patients were diagnosed with DHZ, with a male predominance (65 patients, 59.63%) and 44 female patients (40.37%). The mean age of the patients was 68.6\u202fyears. Advanced age (\u226565\u202fyears) was the most prevalent demographic risk factor. In the assessment of prognostic outcomes, concomitant conditions including hypertension, diabetes, and cancer, along with severe pain (VAS score 7\u201310), were significantly associated with an increased risk of postherpetic neuralgia in a univariate analysis. Furthermore, a multivariable logistic regression analysis identified cancer as an independent risk factor for prolonged disease duration (OR\u202f=\u202f4.271,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.002).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study identified advanced age, cardiovascular disease, and chronic inflammation as independent risk factors for DHZ, highlighting potential target groups for vaccination. Moreover, factors such as hypertension, diabetes, and severe initial pain were associated with postherpetic neuralgia (PHN) in a univariate analysis, suggesting avenues for early attention. These findings highlight the importance of early recognition, aggressive management, and, most importantly, targeted preventive vaccination with the non-live recombinant vaccine in high-risk populations, including cancer patients, to reduce the substantial morbidity associated with disseminated herpes zoster.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1760499","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T05:33:45Z","timestamp":1770183225000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Disseminated herpes zoster in adults: a single-center retrospective study on clinical spectrum and risk factors for adverse outcomes"],"prefix":"10.3389","volume":"13","author":[{"given":"Jia-luo","family":"Cai","sequence":"first","affiliation":[{"name":"Department of Rehabilitation, University-Town Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-guo","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, University-Town Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-rui","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, University-Town Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3390\/v14050982","article-title":"The biology of varicella-zoster virus replication in the skin","volume":"14","author":"Tommasi","year":"2022","journal-title":"Viruses"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3810\/pgm.2013.09.2703","article-title":"Herpes zoster: diagnostic, therapeutic, and preventive approaches","volume":"125","author":"Bader","year":"2013","journal-title":"Postgrad Med"},{"key":"ref4","first-page":"321","article-title":"Atypical disseminated herpes zoster: management guidelines in immunocompromised patients","volume":"100","author":"Lewis","year":"2017","journal-title":"Cutis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3949\/ccjm.91a.24019","article-title":"Preventing herpes zoster in immunocompromised patients: current concepts","volume":"91","author":"Calabrese","year":"2024","journal-title":"Cleve Clin J Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1128\/cmr.9.3.361","article-title":"Varicella-zoster virus","volume":"9","author":"Arvin","year":"1996","journal-title":"Clin Microbiol Rev"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jcv.2008.06.018","article-title":"A rare case of disseminated shingles in an immunocompetent patient following a 7-day treatment with oral valacyclovir","volume":"43","author":"Burdett","year":"2008","journal-title":"J Clin Virol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5070\/D3213022994","article-title":"Varicella zoster virus encephalitis in a patient with disseminated herpes zoster: report and review of the literature","volume":"21","author":"Ellis","year":"2014","journal-title":"Dermatol Online J"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5070\/D32310036993","article-title":"Non-dermatomal varicella-zoster skin infection: disseminated cutaneous herpes zoster without dermatome in an immunosuppressed woman","volume":"23","author":"Osborn","year":"2017","journal-title":"Dermatol Online J"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.7326\/annals-24-02409","article-title":"Effectiveness of recombinant herpes zoster vaccine in the U.S. Medicare population, 2018 to 2019, by immunocompetence and prior receipt of live zoster vaccine","volume":"178","author":"Vielot","year":"2025","journal-title":"Ann Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.7326\/m23-2023","article-title":"Effectiveness of recombinant zoster vaccine against herpes zoster in a real-world setting","volume":"177","author":"Zerbo","year":"2024","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.cmi.2024.03.017","article-title":"Characteristics, management and outcome of herpes simplex and varicella-zoster virus encephalitis: a multicentre prospective cohort study","volume":"30","author":"Poussier","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/v15020439","article-title":"Herpes simplex virus and varicella zoster virus infections in Cancer patients","volume":"15","author":"Tayyar","year":"2023","journal-title":"Viruses"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5070\/D3213022343","article-title":"Disseminated varicella-zoster virus in an immunocompetent adult","volume":"21","author":"Petrun","year":"2015","journal-title":"Dermatol Online J"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3344\/kjp.2013.26.2.195","article-title":"Disseminated herpes zoster in an immunocompetent elderly patient","volume":"26","author":"Yoon","year":"2013","journal-title":"Korean J Pain"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.2147\/idr.S314220","article-title":"Disseminated herpes zoster on a child with systemic lupus erythematosus and lupus nephritis","volume":"14","author":"Widasmara","year":"2021","journal-title":"Infect Drug Resist"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"ofw205","DOI":"10.1093\/ofid\/ofw205","article-title":"Risk of herpes zoster in individuals on biologics, disease-modifying antirheumatic drugs, and\/or corticosteroids for autoimmune diseases: a systematic review and Meta-analysis","volume":"3","author":"Marra","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/vaccines9010023","article-title":"Corticosteroids contribute to serious adverse events following live attenuated varicella vaccination and live attenuated zoster vaccination","volume":"9","author":"Price","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e29629","DOI":"10.1002\/jmv.29629","article-title":"A systematic review and meta-analysis of herpes zoster occurrence\/recurrence after COVID-19 infection and vaccination","volume":"96","author":"Wang","year":"2024","journal-title":"J Med Virol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1038\/s41598-023-29667-w","article-title":"Herpes zoster and long-term vascular risk: a retrospective cohort study","volume":"13","author":"Horev","year":"2023","journal-title":"Sci Rep"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1212\/wnl.0000000000000584","article-title":"Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK","volume":"83","author":"Breuer","year":"2014","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1093\/infdis\/jiy385","article-title":"Herpes zoster: epidemiological links with stroke and myocardial infarction","volume":"218","author":"Warren-Gash","year":"2018","journal-title":"J Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/ana.410440513","article-title":"Unilateral postherpetic neuralgia is associated with bilateral sensory neuron damage","volume":"44","author":"Oaklander","year":"1998","journal-title":"Ann Neurol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s40266-012-0014-3","article-title":"Diagnosing and managing postherpetic neuralgia","volume":"29","author":"Nalamachu","year":"2012","journal-title":"Drugs Aging"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/s2666-7568(22)00039-3","article-title":"Post-licensure zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in older adults: a systematic review and meta-analysis","volume":"3","author":"Mbinta","year":"2022","journal-title":"Lancet Healthy Longev"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.amepre.2024.06.018","article-title":"Zoster vaccine lowers stroke and myocardial infarction risk in chronic disease","volume":"67","author":"Helm","year":"2024","journal-title":"Am J Prev Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e067287","DOI":"10.1136\/bmjopen-2022-067287","article-title":"Disseminated varicella zoster virus infection following live attenuated herpes zoster vaccine: descriptive analysis of reports to Australia\u2019s spontaneous vaccine pharmacovigilance system, 2016-2020","volume":"13","author":"Li-Kim-Moy","year":"2023","journal-title":"BMJ Open"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1760499\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T05:33:46Z","timestamp":1770183226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1760499\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":28,"alternative-id":["10.3389\/fmed.2026.1760499"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1760499","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"article-number":"1760499"}}